Hummingbird Bioscience logo

Hummingbird Bioscience

Leveraging a novel antibody platform, Hummingbird Bioscience focuses on the discovery and early development of oncology drugs. Hummingbird Bioscience, is a biotech company, utilizing systems and computational systems biology to develop novel therapies for disease areas and geographies with major unmet need including cancer.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.hummingbirdbioscience.com
Founded2013
Disease Focus
Development Stage
STOCK CODENon Listed
Address
28 Seah Street,#03-01188384
Singapore
Singapore
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/hummingbird-bioscience
” connections=”true” suffix=””]

Hummingbirds rational antibody design technology platform including ONTarget_, mAbPredict_(computational tool that identifies epitopes) and mAbHITS_ have the ability to create monoclonal antibodies targeting the complex signalling pathways that drive cancer.

In May 2017, Hummingbird Bioscience closed a venture funding round of an undisclosed amount from DeCheng Capital.